Serum miR-493-3p as a diagnostic biomarker and epigenetic regulator targeting DPY30 in pediatric acute lymphoblastic leukemia

Hong Yang, Yong Xu, Xiaoying Zhang, Yanli Wang, Zhaojian Li

Open source

DOI
10.1007/s00277-025-06681-8
Published
2025-11-18
Container
Annals of Hematology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00277-025-06681-8,
  title = {Serum miR-493-3p as a diagnostic biomarker and epigenetic regulator targeting DPY30 in pediatric acute lymphoblastic leukemia},
  author = {Hong Yang and Yong Xu and Xiaoying Zhang and Yanli Wang and Zhaojian Li},
  year = {2025},
  journal = {Annals of Hematology},
  doi = {10.1007/s00277-025-06681-8},
  url = {https://doi.org/10.1007/s00277-025-06681-8}
}

RIS

TY  - JOUR
TI  - Serum miR-493-3p as a diagnostic biomarker and epigenetic regulator targeting DPY30 in pediatric acute lymphoblastic leukemia
AU  - Hong Yang
AU  - Yong Xu
AU  - Xiaoying Zhang
AU  - Yanli Wang
AU  - Zhaojian Li
PY  - 2025
JO  - Annals of Hematology
DO  - 10.1007/s00277-025-06681-8
UR  - https://doi.org/10.1007/s00277-025-06681-8
ER  - 

APA

Yang, H., Xu, Y., Zhang, X., Wang, Y., & Li, Z. (2025). Serum miR-493-3p as a diagnostic biomarker and epigenetic regulator targeting DPY30 in pediatric acute lymphoblastic leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-025-06681-8

Source records